Abstract
An ambulatory facility of a hemopoietic stem cell transplant (HSCT) service is essential for the purposes of pre- and post-transplant care of the patients and donors in the setting of allogeneic transplantation. The care of patients in this facility will be optimized by the presence of well-established protocols for the usual procedures undertaken there, which may include medical evaluation, fluid and electrolyte replacement, delivery of specialized parenteral medications, and in the case of some facilities, the delivery of conditioning chemotherapy and the infusion of the stem cell product itself. Fundamental to a successful ambulatory facility is an adequately trained and staffed nursing contingent; access to pharmacy, blood bank, and investigative services; and close relations with an emergency care facility, as well as inpatient wards capable of accepting acutely and sub-acutely ill patients after HSCT. Ideally, the medical staff will be part of the same team caring for the patients when they are inpatients. An efficiently run ambulatory facility for HSCT patients will have a consulting room facility nearby or integrated within the ambulatory care center.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Niederwieser D, Baldomero H, Szer J, Gratwohl M, Aljurf M, Atsuta Y, et al. Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey. Bone Marrow Transplant. 2016;51:778–85.
Majhail NS, Mau LW, Chitphakdithai P, Payton T, Eckrich M, Joffe S, et al. National survey of hematopoietic cell transplantation center personnel, infrastructure, and models of care delivery. Biol Blood Marrow Transplant. 2015;21:1308–14.
McDiarmid D, Hutton B, Atkins H, Bence-Bruckler I, Bredeson C, Sabri E, Huebsch L. Performing allogeneic and autologous hematopoietic SCT in the outpatient setting: effects on infectious complications and early transplant outcomes. Bone Marrow Transplant. 2010;45:1220–6.
Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C, et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2012;18:348–71.
Carpenter PA, Englund JA. How I vaccinate blood and marrow transplant recipients. Blood. 2016;127:2824–32.
Viner Smith E, Tierney AC, Klarica D, Walker P, Avery S. Impact of a lifestyle modification program on the metabolic syndrome and associated risk factors in long-term survivors of stem cell transplantation. Bone Marrow Transplant. 2016;51:722–4.
Lisenko K, Stadtherr P, Bruckner T, Pavel P, Heilig CE, Schmitt A, et al. Bone marrow harvesting of allogeneic donors in an outpatient setting: a single-center experience. Biol Blood Marrow Transplant. 2016;22:470–4.
Hayes-Lattin B, Leis JF, Maziarz RT. Isolation in the allogeneic transplant environment: how protective is it? Bone Marrow Transplant. 2005;36:373–81.
Krasuska ME, Dmoszyńska A, Daniluk J, Stanisławek A. Information needs of the patients undergoing bone marrow transplantation. Ann Univ Mariae Curie Sklodowska Med. 2002;57:178–85.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Szer, J. (2018). Outpatient HSCT Unit. In: Gluckman, É., Niederwieser, D., Aljurf, M. (eds) Establishing a Hematopoietic Stem Cell Transplantation Unit . Springer, Cham. https://doi.org/10.1007/978-3-319-59358-6_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-59358-6_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-59356-2
Online ISBN: 978-3-319-59358-6
eBook Packages: MedicineMedicine (R0)